View Article

Abstract

Lawsone is a naturally occurring naphthoquinone derived from the leaves of Lawsonia inermis. It exhibits diverse pharmacological activities including anticancer, antimicrobial, antioxidant, anti-inflammatory, and antiviral effects. Recent advancements in synthetic modification, glycoconjugation strategies, and molecular docking studies have expanded its therapeutic relevance. This review summarizes the chemistry, synthesis, biological activities, structure–activity relationships, and computational evaluation of lawsone and its derivatives. Special emphasis is placed on targeted drug delivery approaches and the potential role of lawsone-based hybrids in modern medicinal chemistry.ObjectiveTo comprehensively review the chemical properties, synthetic modifications, pharmacological activities, molecular docking studies, and therapeutic potential of lawsone and its derivatives.MethodsA systematic literature review was conducted using peer-reviewed articles indexed in scientific databases such as PubMed and Google Scholar. Studies focusing on synthesis, in vitro and in vivo biological evaluation, molecular docking, and drug-target interactions of lawsone derivatives were analyzed and critically summarized.ResultsThe collected studies indicate that structural modification of lawsone significantly enhances its biological activity. Lawsone derivatives show promising anticancer effects through apoptosis induction, reactive oxygen species generation, and enzyme inhibition. Molecular docking studies demonstrate strong binding affinity with cancer-associated and microbial targets. Glycoconjugate and hybrid derivatives improve selectivity and bioavailability.ConclusionLawsone represents a versatile pharmacophore with significant therapeutic potential. Strategic structural modifications and targeted delivery approaches may further enhance its efficacy. Future studies should focus on clinical Lawsone is a naturally occurring naphthoquinone derived from the leaves of Lawsonia inermis. It exhibits diverse pharmacological activities including anticancer, antimicrobial, antioxidant, anti-inflammatory, and antiviral effects. Recent advancements in synthetic modification, glycoconjugation strategies, and molecular docking studies have expanded its therapeutic relevance. This review summarizes the chemistry, synthesis, biological activities, structure–activity relationships, and computational evaluation of lawsone and its derivatives. Special emphasis is placed on targeted drug delivery approaches and the potential role of lawsone-based hybrids in modern medicinal chemistry.ObjectiveTo comprehensively review the chemical properties, synthetic modifications, pharmacological activities, molecular docking studies, and therapeutic potential of lawsone and its derivatives.MethodsA systematic literature review was conducted using peer-reviewed articles indexed in scientific databases such as PubMed and Google Scholar. Studies focusing on synthesis, in vitro and in vivo biological evaluation, molecular docking, and drug-target interactions of lawsone derivatives were analyzed and critically summarized.ResultsThe collected studies indicate that structural modification of lawsone significantly enhances its biological activity. Lawsone derivatives show promising anticancer effects through apoptosis induction, reactive oxygen species generation, and enzyme inhibition. Molecular docking studies demonstrate strong binding affinity with cancer-associated and microbial targets. Glycoconjugate and hybrid derivatives improve selectivity and bioavailability.ConclusionLawsone represents a versatile pharmacophore with significant therapeutic potential. Strategic structural modifications and targeted delivery approaches may further enhance its efficacy. Future studies should focus on clinical

Keywords

Lawsone; 2-hydroxy-1,4-naphthoquinone; Naphthoquinone derivatives; Anticancer activity; Molecular docking; Glycoconjugates; Drug design

Introduction

1.1 Natural Source and Chemical Nature of Lawsone

1.1.1 Natural Source of Lawsone

Lawsone (2-hydroxy-1,4-naphthoquinone) is a naturally occurring naphthoquinone predominantly isolated from the leaves of Lawsonia inermis, a flowering plant belonging to the family Lythraceae. The plant is widely distributed in tropical and subtropical regions including India, North Africa, and the Middle East. Traditionally, L. inermis has been used as a natural dye for skin, hair, and textiles due to the strong chromophoric properties of lawsone [1].

The biosynthesis of lawsone in L. inermis occurs via the polyketide pathway, where acetate units undergo cyclization and oxidation to generate the naphthoquinone core structure [2]. The highest concentration of lawsone is found in the leaves, while smaller amounts are detected in stems and flowers. Extraction of lawsone is commonly performed using polar organic solvents such as ethanol, methanol, or aqueous mixtures, followed by chromatographic purification techniques [3].

Beyond its dyeing applications, lawsone has attracted scientific interest because of its broad spectrum of biological activities including antimicrobial, antioxidant, anti-inflammatory, antimalarial, and anticancer properties [4,5]. The pharmacological potential of lawsone has stimulated extensive derivatization studies to enhance its bioactivity and reduce toxicity.

1.1.2 Chemical Structure and Physicochemical Properties

Chemically, lawsone is designated as 2-hydroxy-1,4-naphthoquinone with the molecular formula C??H?O? and molecular weight 174.15 g/mol. Structurally, it consists of:

  • A 1,4-naphthoquinone core
  • A phenolic hydroxyl group at the C-2 position
  • A conjugated π-electron system

The quinone carbonyl groups (C=O) are strongly electrophilic and contribute to redox cycling properties, while the phenolic hydroxyl group enhances hydrogen bonding and chelation capacity [6]. The conjugated system is responsible for its intense orange-red coloration and UV-visible absorption maxima around 270–280 nm and 420–450 nm [7].

Lawsone exhibits keto–enol tautomerism, although the enol form is generally stabilized through intramolecular hydrogen bonding between the hydroxyl proton and adjacent carbonyl oxygen [8]. This tautomeric equilibrium significantly influences its reactivity in nucleophilic addition, Michael reactions, and Mannich-type condensations.

1.2.1 Early Discovery and Natural Identification

The study of naphthoquinones dates back to the late nineteenth century, when plant-derived pigments were systematically isolated and characterized. Early investigations into dye-yielding plants revealed the presence of quinonoid structures responsible for coloration and biological properties. One of the earliest characterized compounds was Juglone, isolated from Juglans regia, which demonstrated allelopathic and antimicrobial properties [9].

Similarly, Plumbagin, isolated from plants of the genus Plumbago, further established the importance of naturally occurring naphthoquinones in medicinal chemistry [10]. These early discoveries confirmed the presence of a fused benzene–quinone ring system capable of redox transformations.

By the early 20th century, structural elucidation through classical degradation reactions and oxidative studies firmly established the 1,4-naphthoquinone core [11].

1.2.2 Evolution of Synthetic Naphthoquinone Chemistry

The mid-20th century marked significant progress in synthetic methodologies. Laboratory synthesis of 1,4-naphthoquinone derivatives became possible via controlled oxidation of substituted naphthols using chromic acid, nitric acid, or silver oxide [12].

The quinone nucleus was soon recognized for its strong electrophilic nature, allowing:

  • Michael-type nucleophilic addition
  • Amination reactions
  • Thiol addition
  • Electrophilic substitution

The activated C-2 and C-3 positions became primary sites for structural diversification [13].

Subsequently, condensation reactions with 1,2-diamines and thiols led to the formation of fused heterocyclic systems such as quinoxalines and benzothiazines. These reactions expanded the chemical versatility of naphthoquinones beyond simple substitution chemistry [14].

1.2.3 Medicinal Relevance and Redox Chemistry

The discovery of vitamin K, a biologically essential naphthoquinone derivative, marked a pivotal moment in understanding the pharmacological relevance of quinones [15]. This finding demonstrated that quinones play crucial physiological roles, particularly in blood coagulation pathways.

Mechanistic studies revealed that naphthoquinones exert biological effects through:

  • Redox cycling
  • Reactive oxygen species (ROS) generation
  • Covalent modification of thiol-containing proteins
  • Enzyme inhibition

These properties underpin both their therapeutic activity and potential cytotoxicity [16].

Natural naphthoquinones such as lapachol and β-lapachone gained attention for their anticancer and antiparasitic effects, reinforcing interest in quinone-based drug development [17].

  1. Synthetic Strategies for Lawsone-Derived Heterocycles

2.1. Multicomponent Reactions (MCRs) in the Synthesis of Lawsone-Derived Heterocycles

Multicomponent reactions (MCRs) have emerged as one of the most powerful synthetic strategies for the rapid construction of structurally diverse lawsone-derived heterocyclic compounds. MCRs involve the combination of three or more reactants in a single reaction vessel to generate complex products with high atom economy and operational simplicity. In the context of naphthoquinone chemistry, the electrophilic nature of lawsone makes it an excellent Michael acceptor and condensation partner in multicomponent systems [18].

2.1.1 General Reactivity of Lawsone in MCRs

Lawsone (2-hydroxy-1,4-naphthoquinone) contains:

  • An activated C-3 position
  • Two electrophilic carbonyl groups
  • A phenolic hydroxyl group capable of hydrogen bonding

These structural features allow participation in:

  • Knoevenagel condensation
  • Michael addition
  • Mannich-type reactions
  • Cyclocondensation processes

The synergistic reactivity of these functional groups enables the formation of oxygen-, nitrogen-, and sulfur-containing heterocycles in one-pot protocols [19].

2.1.2 Three-Component Reactions: Formation of Pyran and Chromene Systems

One of the most widely reported MCR strategies involves the reaction of lawsone, aromatic aldehydes, and active methylene compounds such as malononitrile or ethyl cyanoacetate.

Mechanistic Pathway

  1. Knoevenagel condensation between aldehyde and malononitrile
  2. Michael addition of lawsone at the activated C-3 position
  3. Intramolecular cyclization
  4. Proton transfer and aromatization

This strategy efficiently produces pyran-fused naphthoquinone derivatives with good yields under mild conditions [20].

Recent studies demonstrate that these heterocycles exhibit significant cytotoxic and antioxidant properties, highlighting the importance of MCR-derived scaffolds in medicinal chemistry [21].

2.1.3 Mannich-Type Multicomponent Reactions

Lawsone also participates in Mannich-based MCRs involving amines and aldehydes. The reaction proceeds via iminium ion formation followed by nucleophilic attack at the C-3 position of lawsone.

Such reactions provide access to aminoalkylated derivatives and fused nitrogen-containing heterocycles. These products often show enhanced solubility and improved biological activity compared to the parent compound [22].

2.2 Mannich Reaction of Lawsone

The Mannich reaction represents one of the most versatile and extensively explored methodologies for functionalizing lawsone at the C-3 position. Due to the activated methylene character of the C-3 carbon in 2-hydroxy-1,4-naphthoquinone (lawsone), it readily undergoes aminomethylation in the presence of aldehydes and amines. This transformation has become a cornerstone in the synthesis of nitrogen-containing heterocycles derived from lawsone [23].

2.2.1 General Mechanism of the Mannich Reaction

The classical Mannich reaction involves three components:

  1. An aldehyde (commonly formaldehyde or aromatic aldehydes)
  2. A primary or secondary amine
  3. An active hydrogen compound (lawsone in this case)

Mechanistic Pathway

Step 1: Formation of an iminium ion from aldehyde and amine
 Step 2: Nucleophilic attack of the C-3 carbon of lawsone on the iminium ion
 Step 3: Proton transfer and stabilization of the aminomethylated product

The resonance stabilization of the intermediate anion formed at C-3 enhances regioselectivity. The phenolic hydroxyl group further assists via intramolecular hydrogen bonding, stabilizing the transition state [24].

2.2.2 Mono- and Bis-Mannich Bases of Lawsone

Depending on reaction stoichiometry and amine type, both mono- and bis-Mannich derivatives can be synthesized. Mono-substituted derivatives typically form under controlled molar ratios, while bis-aminomethyl derivatives may form under excess formaldehyde conditions [25].

These derivatives are structurally important because the introduction of aminoalkyl chains:

  • Enhances water solubility
  • Modifies lipophilicity
  • Improves pharmacokinetic behavior
  • Alters redox properties

Such modifications significantly impact biological activity profiles.

2.2.3 Cyclized Mannich Products and Fused Heterocycles

In several cases, intramolecular cyclization occurs after Mannich condensation, leading to fused heterocyclic systems such as:

  • Benzoxazine derivatives
  • Isoindolinone frameworks
  • Tetrahydroquinoline-fused systems

These transformations occur when bifunctional amines or ortho-substituted aldehydes are employed, enabling ring closure via nucleophilic attack on the quinone carbonyl group [26].

Such fused systems often demonstrate enhanced cytotoxic and antimicrobial activities compared to simple Mannich bases.

2.2.4 Green and Catalytic Mannich Reactions

Recent studies have emphasized environmentally friendly conditions for Mannich reactions involving lawsone, including:

  • Solvent-free grinding methods
  • Ionic liquid catalysis
  • Microwave-assisted synthesis
  • Magnetic nanoparticle catalysts

These approaches reduce reaction time, improve yields, and eliminate hazardous solvents, aligning with green chemistry principles [27].

Microwave irradiation, in particular, accelerates iminium ion formation and nucleophilic addition, significantly shortening reaction times from hours to minutes [28].

2.2.5 Biological Activities of Mannich-Type Lawsone Derivatives

Mannich-modified lawsone derivatives have demonstrated diverse biological properties:

Anticancer Activity

Several aminomethylated derivatives induce apoptosis via ROS generation and mitochondrial dysfunction. Electron-withdrawing substituents on the aromatic amine improve cytotoxic potency [29].

Antimicrobial Activity

Mannich bases of lawsone show activity against Gram-positive bacteria, including resistant strains. The presence of tertiary amine groups enhances membrane permeability [30].

Enzyme Inhibition

Certain Mannich derivatives exhibit inhibitory effects on carbonic anhydrase and acetylcholinesterase, suggesting potential applications in metabolic and neurodegenerative disorders [31].

2.3 Fused Heterocycles

Lawsone (2-hydroxy-1,4-naphthoquinone) is a versatile synthon for the construction of fused heterocyclic systems due to its electrophilic quinone carbonyl groups and nucleophilic C-3 position. Its ability to undergo cyclization, condensation, and oxidative annulation reactions makes it an important precursor for pharmacologically relevant fused heterocycles. Several classes of fused scaffolds derived from lawsone exhibit antimicrobial, anticancer, anti-inflammatory, and enzyme inhibitory activities.

2.3.1 Isoindolinones

Isoindolinone-fused naphthoquinones are typically synthesized through condensation of lawsone with primary amines or via multicomponent reactions involving aldehydes and nitrogen nucleophiles. The formation generally proceeds through initial nucleophilic addition at the C-3 position followed by intramolecular cyclization and oxidative aromatization.

These derivatives have attracted attention due to their cytotoxic and antimicrobial activities. Studies report that isoindolinone–naphthoquinone hybrids exhibit enhanced redox cycling ability and reactive oxygen species (ROS) generation, contributing to anticancer activity [32]. Structure–activity relationship (SAR) analysis suggests that electron-withdrawing substituents improve biological potency [33].

2.3.2 Benzothiazines

Benzothiazine-fused systems are commonly prepared via reaction of lawsone with o-aminothiophenols under oxidative cyclization conditions. The reaction proceeds through Michael addition followed by intramolecular nucleophilic attack and ring closure.

These scaffolds demonstrate strong antimicrobial and antioxidant properties. Benzothiazine–naphthoquinone hybrids have also shown inhibitory activity against bacterial strains and cancer cell lines [34]. The presence of sulfur enhances lipophilicity and biological interaction with enzyme targets [35].

2.3.3 Quinoxalines

Quinoxaline-fused naphthoquinones are synthesized via condensation of lawsone with o-phenylenediamines. The reaction involves nucleophilic attack on the quinone carbonyl followed by cyclodehydration. These transformations are often facilitated by acid catalysis or green synthetic approaches.

Quinoxaline hybrids derived from lawsone display broad-spectrum antimicrobial and anticancer properties. Their biological activity is often attributed to DNA intercalation and enzyme inhibition mechanisms [36]. Additionally, quinoxaline fusion enhances molecular planarity, improving π–π stacking interactions with biological targets [37].

2.3.4 Thiazoles

Thiazole-fused naphthoquinones are typically synthesized through condensation of lawsone with thioamides or α-haloketones containing sulfur and nitrogen functionalities. Cyclization generally proceeds via nucleophilic substitution followed by oxidative ring closure.

Thiazole incorporation significantly enhances antimicrobial and anticancer potential. Studies show that thiazole–naphthoquinone conjugates possess strong cytotoxic effects through apoptosis induction and mitochondrial pathway activation [38]. These derivatives also demonstrate promising anti-inflammatory activity [39].

2.3.5 Oxazoles

Oxazole-fused systems can be synthesized via condensation of lawsone with amino alcohols or α-amino carbonyl compounds, followed by cyclodehydration. The reaction is often catalyzed by acids or carried out under microwave-assisted conditions to improve yield.

Oxazole–naphthoquinone derivatives exhibit notable antimicrobial and anticancer properties. Their activity is frequently linked to interference with cellular redox balance and inhibition of topoisomerase enzymes [40]. The heteroatom-rich oxazole ring enhances hydrogen bonding capacity, improving receptor binding affinity [41].

2.4 Green and Sustainable Synthesis

Green and sustainable synthesis has emerged as a central theme in modern organic chemistry, emphasizing environmentally benign methodologies, reduced waste generation, energy efficiency, and safer reagents. In the context of lawsone (2-hydroxy-1,4-naphthoquinone), green synthetic strategies have been widely explored due to its importance in medicinal and materials chemistry. Sustainable approaches aim to improve the atom economy, reduce hazardous solvents, and employ renewable or recyclable catalytic systems.

2.4.1 Solvent-Free and Microwave-Assisted Synthesis

Solvent-free reactions significantly reduce environmental burden and enhance reaction efficiency. Lawsone-based condensations and multicomponent reactions have been successfully performed under solvent-free conditions, often resulting in shorter reaction times and higher yields. Microwave irradiation further accelerates these transformations by uniform heating and energy-efficient activation of reactants.

Microwave-assisted synthesis of naphthoquinone derivatives has demonstrated improved reaction rates and selectivity compared to conventional heating methods [42]. These methods reduce solvent consumption and minimize by-product formation, aligning with green chemistry principles [43].

2.4.2 Aqueous and Ethanol-Based Green Solvents

Water and bio-based solvents such as ethanol are considered environmentally friendly alternatives to chlorinated and toxic organic solvents. Lawsone undergoes various cyclization and condensation reactions efficiently in aqueous or ethanol media, often in the presence of mild catalysts.

Several studies have reported the successful synthesis of heterocyclic derivatives of lawsone in water using recyclable catalysts, achieving high yields and simplified purification [44]. Ethanol-mediated multicomponent reactions involving lawsone have also demonstrated excellent atom economy and operational simplicity [45].

2.4.3 Green Catalysts and Biocatalysis

The use of green catalysts—including heterogeneous catalysts, organocatalysts, and biocatalysts—has significantly advanced sustainable lawsone chemistry. Solid acid catalysts, ionic liquids, and metal-free catalytic systems have been applied to promote cyclization and Mannich-type reactions of lawsone under mild conditions.

Biocatalytic approaches, including enzyme-mediated transformations, offer high selectivity and minimal environmental impact. Enzymatic oxidation and functionalization of naphthoquinones have been explored as eco-friendly alternatives to conventional oxidation methods [46]. Additionally, reusable heterogeneous catalysts such as silica-supported acids and magnetic nanoparticles have been employed for efficient recovery and reuse [47].

2.4.4 Ultrasound and Mechanochemical Synthesis

Ultrasound-assisted synthesis enhances reaction rates through acoustic cavitation, improving mass transfer and reducing reaction time. Lawsone-derived heterocycles have been synthesized efficiently under ultrasonic irradiation with reduced solvent usage [48].

Mechanochemical synthesis, involving grinding of reactants without solvent, represents another sustainable approach. This technique improves energy efficiency and eliminates the need for harmful solvents. Reports demonstrate that mechanochemical methods can produce lawsone-based heterocycles with high yield and minimal waste [49].

2.4.5 Biomass-Derived and Renewable Precursors

Lawsone itself is a naturally occurring compound obtained from Lawsonia inermis (henna). The use of plant-derived lawsone aligns with renewable feedstock principles of green chemistry. Extraction and purification methods have been optimized using environmentally friendly solvents and reduced energy input [50].

3. Structural Elucidation Techniques

Structural characterization plays a crucial role in confirming the successful synthesis of lawsone-derived compounds and fused heterocycles. Advanced spectroscopic and computational techniques provide detailed information regarding molecular framework, functional groups, stereochemistry, and electronic properties. For lawsone (2-hydroxy-1,4-naphthoquinone) derivatives, a combination of NMR, FT-IR, HRMS, X-ray crystallography, and computational methods such as DFT and molecular docking are routinely employed to establish structure–activity relationships.

3.1 NMR Spectroscopy

Nuclear Magnetic Resonance (NMR) spectroscopy is one of the most powerful techniques for structural elucidation.

In lawsone derivatives:

  • ¹H NMR confirms aromatic proton environments and substitution patterns.
  • ¹³C NMR identifies quinone carbonyl carbons (typically δ 175–185 ppm).
  • 2D NMR techniques (COSY, HSQC, HMBC) help determine proton–proton and proton–carbon connectivity.
  • Intramolecular hydrogen bonding involving the phenolic –OH group is often observed as a downfield singlet in ¹H NMR.

Studies have demonstrated that detailed NMR analysis enables unambiguous confirmation of cyclization in fused naphthoquinone systems [51]. Advanced multidimensional NMR techniques are particularly useful in distinguishing regioisomers formed during Mannich or multicomponent reactions [52].

3.2 FT-IR Spectroscopy

Fourier Transform Infrared (FT-IR) spectroscopy provides rapid identification of functional groups.

Key diagnostic peaks in lawsone derivatives include:

  • Quinone C=O stretching: ~1650–1680 cm?¹
  • Phenolic O–H stretching: broad band ~3200–3500 cm?¹
  • C–N, C–S, or C–O bands depending on heterocyclic incorporation

FT-IR is especially useful in confirming condensation reactions, cyclization, and formation of new heterocyclic systems. Comparative IR studies have been employed to validate structural modifications in naphthoquinone scaffolds [53].

3.3 High-Resolution Mass Spectrometry (HRMS)

High-Resolution Mass Spectrometry (HRMS) provides precise molecular weight determination and elemental composition.

For lawsone derivatives, HRMS:

  • Confirms molecular formula with high accuracy
  • Detects isotopic patterns (especially for halogenated derivatives)
  • Supports structural proposals in multicomponent and fused systems

Electrospray ionization (ESI) and MALDI techniques are commonly used for quinone derivatives. HRMS plays a critical role in identifying intermediate species and confirming final products in synthetic studies [54].

3.4 X-Ray Crystallography

Single-crystal X-ray diffraction (SCXRD) is considered the gold standard for definitive structural confirmation. It provides:

  • Three-dimensional molecular geometry
  • Bond lengths and bond angles
  • Crystal packing interactions
  • Hydrogen bonding networks
  • Absolute configuration (when applicable)

X-ray studies on naphthoquinone derivatives have confirmed fused ring formation and intramolecular hydrogen bonding patterns [55]. Crystallographic analysis also helps in understanding π–π stacking interactions, which are important for biological activity [56].

3.5 DFT and Molecular Docking

Density Functional Theory (DFT) calculations provide insights into electronic structure, HOMO–LUMO energy gaps, molecular stability, and reactivity.

For lawsone derivatives, DFT studies help:

  • Predict optimized molecular geometry
  • Analyze charge distribution
  • Understand redox behavior
  • Correlate electronic properties with biological activity

Computational studies have demonstrated that DFT-calculated parameters correlate well with experimental spectroscopic data [57].

Molecular docking is widely used to predict binding interactions between lawsone derivatives and biological targets such as enzymes or receptors. Docking studies provide:

  • Binding affinity scores
  • Hydrogen bonding interactions
  • Hydrophobic and π–π interactions
  • Structure–activity relationship validation

Docking investigations of naphthoquinone derivatives have shown promising interactions with anticancer and antimicrobial targets, supporting experimental findings [58].

4. Chemo-Biological Applications

Lawsone (2-hydroxy-1,4-naphthoquinone) and its synthetic derivatives have attracted considerable interest due to their broad spectrum of biological activities. The quinone nucleus plays a central role in redox cycling, reactive oxygen species (ROS) generation, enzyme inhibition, and DNA interaction. Structural modification through Mannich reactions, heterocyclic fusion, and multicomponent strategies has significantly enhanced the pharmacological potential of lawsone derivatives.

This section summarizes major chemo-biological applications of lawsone-based compounds.

4.1 Anticancer Activity

Naphthoquinone derivatives are well known for their cytotoxic properties. The anticancer mechanism of lawsone derivatives is primarily attributed to:

  • Redox cycling and ROS generation
  • Induction of apoptosis
  • DNA intercalation
  • Topoisomerase inhibition
  • Mitochondrial dysfunction

Quinone-based compounds such as β-lapachone demonstrate potent anticancer activity by targeting NAD(P)H:quinone oxidoreductase 1 (NQO1), leading to selective cancer cell death [59]. Structural similarity between lawsone and bioactive naphthoquinones has inspired development of lawsone-based anticancer hybrids.

Studies report that Mannich base derivatives of lawsone show enhanced cytotoxicity against breast, lung, and colon cancer cell lines [60]. The introduction of aminoalkyl side chains improves solubility and cellular uptake.

Fused heterocyclic derivatives such as thiazole- and quinoxaline-containing naphthoquinones exhibit apoptosis induction via caspase activation and mitochondrial membrane depolarization [61]. SAR studies reveal that electron-withdrawing substituents increase anticancer potency by stabilizing redox-active intermediates [62].

Additionally, molecular docking studies confirm strong interactions between lawsone derivatives and cancer-related proteins including topoisomerase II and tubulin [63].

4.2 Antimicrobial Activity

Lawsone derivatives exhibit significant antibacterial and antifungal activity. The mechanism involves:

  • Membrane disruption
  • Inhibition of microbial enzymes
  • Oxidative stress induction
  • DNA damage

Natural lawsone extracted from Lawsonia inermis shows inhibitory activity against Gram-positive and Gram-negative bacteria [64]. Structural modification enhances antimicrobial potency.

Mannich bases of lawsone demonstrate improved antibacterial activity against Staphylococcus aureus and Escherichia coli [65]. The presence of nitrogen-containing side chains increases lipophilicity and membrane penetration.

Thiazole- and benzothiazine-fused derivatives show promising antifungal activity against Candida species [66]. Mechanistic studies suggest interference with fungal cell wall synthesis.

Recent investigations also highlight activity against drug-resistant bacterial strains, suggesting that naphthoquinone hybrids may overcome antibiotic resistance [67].

4.3 Antimalarial Activity

Malaria remains a major global health concern, and quinone-based compounds have long been explored as antimalarial agents. The redox-active quinone moiety interferes with parasite mitochondrial electron transport and heme detoxification pathways.

Lapachol and related naphthoquinones exhibit significant activity against Plasmodium falciparum [68]. Lawsone derivatives structurally resemble these active scaffolds and have shown moderate to strong antiplasmodial activity.

Synthetic hybrid molecules combining lawsone with heterocyclic pharmacophores demonstrate improved inhibition of parasite growth [69]. The mechanism is proposed to involve oxidative stress generation within infected erythrocytes.

Recent docking studies suggest interaction with parasite enzymes such as falcipain and dihydrofolate reductase (DHFR), supporting their therapeutic potential [70].

4.4 Antidiabetic and Enzyme Inhibition

Lawsone derivatives have demonstrated promising enzyme inhibitory activity relevant to metabolic disorders.

α-Glucosidase and α-Amylase Inhibition

Naphthoquinone derivatives have shown significant inhibition of carbohydrate-hydrolyzing enzymes, reducing postprandial hyperglycemia [71]. Structural modification enhances binding affinity through hydrogen bonding and π-π stacking interactions.

Protein Tyrosine Phosphatase (PTP1B) Inhibition

PTP1B is a negative regulator of insulin signaling. Quinone-based inhibitors have been explored as potential antidiabetic agents [72].

Acetylcholinesterase (AChE) and Other Enzymes

Lawsone derivatives also inhibit enzymes such as acetylcholinesterase and urease, indicating broader pharmacological relevance [73].

Molecular docking studies demonstrate favorable interactions between substituted lawsone derivatives and active site residues of target enzymes, supporting experimental inhibition data [74].

4.5 Antiplatelet and Cardiovascular Applications

Cardiovascular diseases involve platelet aggregation, oxidative stress, and endothelial dysfunction. Quinone derivatives exhibit both antioxidant and antiplatelet activities.

Studies show that naphthoquinone derivatives inhibit platelet aggregation induced by ADP and collagen [75]. The mechanism may involve modulation of thromboxane synthesis and intracellular calcium signaling.

Lawsone-based compounds also demonstrate vasorelaxant and antioxidant effects, contributing to cardioprotective potential [76].

Furthermore, redox modulation properties of quinones may reduce oxidative damage associated with atherosclerosis [77].

Hybrid molecules combining lawsone with nitric oxide-releasing groups have been proposed to enhance vascular benefits [78].

5. Structure–Activity Relationship (SAR) Discussion

Structure–Activity Relationship (SAR) analysis plays a critical role in understanding how structural modifications of lawsone (2-hydroxy-1,4-naphthoquinone) influence biological activity. The quinone core, phenolic hydroxyl group, and substitution at the C-3 position are key determinants of pharmacological properties. Modifications such as Mannich base formation, heterocyclic fusion, halogenation, and hybridization with pharmacophores significantly alter redox potential, lipophilicity, electronic distribution, and target binding affinity.

5.1 Importance of the Quinone Core

The 1,4-naphthoquinone scaffold is essential for redox cycling and reactive oxygen species (ROS) generation. Quinones undergo one- and two-electron reduction processes, forming semiquinone radicals that contribute to cytotoxicity in cancer cells [79].

Electron-withdrawing substituents on the quinone ring increase electrophilicity and enhance redox potential, often correlating with improved anticancer and antimicrobial activity [80]. However, excessive redox reactivity may increase toxicity toward normal cells, highlighting the need for balanced structural tuning.

5.2 Role of the Phenolic Hydroxyl Group

The hydroxyl group at C-2 of lawsone participates in:

  • Intramolecular hydrogen bonding
  • Metal chelation
  • Modulation of electronic density

Modification of the phenolic –OH (e.g., etherification or esterification) often reduces hydrogen bonding capacity and may decrease biological activity unless compensated by additional pharmacophoric features [81].

Studies indicate that retaining the free hydroxyl group enhances enzyme inhibition and anticancer activity due to its role in hydrogen bond interactions within biological targets [82].

5.3 Substitution at the C-3 Position

The C-3 position is highly reactive and frequently modified through Mannich reactions or Michael additions. Introduction of aminoalkyl substituents:

  • Improves aqueous solubility
  • Enhances membrane permeability
  • Facilitates target binding

Mannich base derivatives demonstrate increased anticancer and antimicrobial activity compared to parent lawsone [83]. SAR studies reveal that tertiary amines with moderate steric bulk provide optimal activity, likely due to improved pharmacokinetic properties [84].

Bulky substituents at C-3 may enhance selectivity but can reduce redox efficiency if steric hindrance limits interaction with enzymatic systems.

5.4 Effect of Heterocyclic Fusion

Fusion of heterocyclic rings such as thiazoles, quinoxalines, benzothiazines, and isoindolinones enhances biological activity by:

  • Increasing molecular rigidity
  • Enhancing π-conjugation
  • Improving DNA intercalation
  • Strengthening enzyme binding interactions

Thiazole-fused derivatives exhibit enhanced cytotoxicity due to increased lipophilicity and mitochondrial targeting ability [85].

Quinoxaline fusion improves planarity and π–π stacking interactions with nucleic acids and enzymes, leading to stronger anticancer and antimicrobial properties [86].

5.5 Electronic and Lipophilic Effects

Lipophilicity (log P) plays a major role in biological activity. Moderate lipophilicity enhances cell membrane penetration, whereas excessive lipophilicity may reduce solubility and bioavailability.

Halogen substitution (Cl, Br, F) often increases lipophilicity and improves antimicrobial potency [87]. Electron-withdrawing groups also stabilize semiquinone intermediates, enhancing redox-mediated cytotoxic effects.

Computational SAR studies show that HOMO–LUMO energy gaps correlate with biological activity, where lower energy gaps often indicate higher reactivity and improved anticancer potential [88].

5.6 Hybridization Strategy

Hybrid molecules combining lawsone with other pharmacophores (e.g., triazoles, sulfonamides, NO-donors) frequently demonstrate synergistic activity [89].

The hybrid approach:

  • Improves multi-target interaction
  • Enhances potency
  • Reduces resistance development

Molecular docking confirms improved binding affinity of hybrid derivatives toward enzymes such as topoisomerase II, α-glucosidase, and DHFR [90].

5.7 Redox Potential and Cytotoxic Selectivity

The biological activity of lawsone derivatives strongly depends on their redox potential. Compounds with optimized redox cycling ability selectively target cancer cells overexpressing NAD(P)H-dependent enzymes such as NQO1 [91].

6. Toxicity and Pharmacokinetic Considerations

Although lawsone (2-hydroxy-1,4-naphthoquinone) and its derivatives demonstrate promising chemo-biological applications, their clinical translation requires careful evaluation of toxicity, pharmacokinetics, and drug-likeness. Quinone-based compounds are well known for redox reactivity, which contributes both to therapeutic effects and potential adverse outcomes. Therefore, understanding toxicity mechanisms, metabolic behavior, and pharmacokinetic limitations is essential for rational drug design.

6.1 Quinone Toxicity Due to Redox Cycling

The quinone moiety undergoes enzymatic one-electron reduction to form semiquinone radicals. These unstable intermediates react with molecular oxygen, generating reactive oxygen species (ROS) such as superoxide anion and hydrogen peroxide. This process, known as redox cycling, can cause oxidative stress, lipid peroxidation, protein modification, and DNA damage [92].

While controlled ROS production contributes to anticancer activity, excessive redox cycling may damage normal tissues. Quinone-induced oxidative stress has been linked to cytotoxicity in hepatocytes and cardiomyocytes [93].

Furthermore, quinones can form covalent adducts with nucleophilic biomolecules (e.g., glutathione, cysteine residues in proteins), leading to enzyme inactivation and cellular dysfunction [94]. The balance between therapeutic redox activity and systemic toxicity remains a central challenge in developing lawsone-based drugs.

6.2 Potential Hepatotoxicity

The liver is particularly vulnerable to quinone-induced toxicity due to its high metabolic activity and cytochrome P450 enzyme expression. Metabolic activation of quinones can generate reactive intermediates that bind to hepatic proteins, triggering oxidative stress and inflammatory responses [95].

Studies have shown that certain naphthoquinones may cause dose-dependent hepatotoxic effects in experimental models [96]. Mechanisms include:

  • Mitochondrial dysfunction
  • Depletion of intracellular glutathione
  • Activation of apoptotic pathways

However, structural modifications such as reduced redox potential, introduction of steric hindrance, or conjugation with protective groups may mitigate hepatotoxic effects [97]. Therefore, SAR-guided optimization is crucial to improve safety profiles.

6.3 Need for In Vivo Validation

Although many lawsone derivatives demonstrate promising in vitro biological activity, translation to clinical application requires rigorous in vivo validation. In vitro assays do not fully capture:

  • Metabolic transformation
  • Bioavailability
  • Tissue distribution
  • Clearance mechanisms
  • Immune response interactions

Animal models are necessary to evaluate pharmacodynamic effects, therapeutic index, and systemic toxicity [98]. Additionally, pharmacokinetic parameters such as half-life (t½), maximum plasma concentration (Cmax), and area under the curve (AUC) must be determined to assess drug viability [99].

Several promising quinone-based compounds have failed during development due to inadequate in vivo stability or unacceptable toxicity, emphasizing the importance of comprehensive preclinical evaluation.

6.4 Pharmacokinetics and Drug-Likeness (Lipinski Rule of Five)

Drug-likeness prediction is an essential early-stage screening strategy. According to Lipinski’s Rule of Five, orally active drug candidates generally satisfy the following criteria [100]:

  • Molecular weight ≤ 500 Da
  • Log P ≤ 5
  • Hydrogen bond donors ≤ 5
  • Hydrogen bond acceptors ≤ 10

Many simple lawsone derivatives fall within these limits; however, extensive heterocyclic fusion or bulky substitutions may increase molecular weight and lipophilicity beyond optimal ranges.

Pharmacokinetic challenges associated with quinones include:

  • Rapid metabolic reduction
  • Poor aqueous solubility
  • Limited oral bioavailability

Strategies to improve pharmacokinetic profiles include:

  • Prodrug development
  • Nanoformulation approaches
  • Hybrid molecule design
  • Structural modification to balance hydrophilicity and lipophilicity [101]

Computational ADME (Absorption, Distribution, Metabolism, Excretion) prediction tools are increasingly employed to evaluate drug-likeness before in vivo testing [102].

RESULTS AND DISCUSSION

This review has comprehensively explored the synthetic routes, structural characterization, and chemo-biological activities of lawsone-derived heterocycles. Based on the results, lawsone, 2-hydroxy-1,4-naphthoquinone, was found to be an extremely versatile pharmacophore, which can be readily modified structurally and chemo-biologically.

7.1 Synthetic Versatility of Lawsone

Throughout the studies, lawsone was found to possess excellent synthetic versatility based on three major features:

Electrophilic quinone carbonyls

Activated C-3 carbon

Hydrogen-bonded phenolic hydroxyl

Through these features, lawsone was found to readily undergo multi-component reactions, which are useful in the formation of structurally diverse heterocycles in a single step. These include the formation of heterocycles bearing the pyran, chromene, quinoxaline, thiazole, and benzothiazine ring systems.

The most productive functionalization approach that came to the forefront was the Mannich reaction. The introduction of aminoalkyl groups at C-3 had a profound effect on physicochemical parameters, particularly solubility and lipophilicity, which in turn had a direct bearing on biological activity. Monomeric as well as bis-Mannich derivatives showed improved pharmacological activity compared to the parent compound.

The fused heterocyclic compounds had improved rigidity and increased π-conjugation. This increased rigidity in the structure improved the planarity of the molecule and increased its interaction with biological macromolecules, particularly DNA and enzymic active sites.

Green chemistry approaches, including solvent-free grinding, microwave, aqueous media, ultrasound, and nanocatalytic methods, have shown promising results in minimizing reaction time and environmental impact without affecting yield. These eco-friendly approaches are gradually becoming an integral part of lawsone chemistry.

7.2 Structural Elucidation and Molecular Confirmation

Spectroscopic and crystallographic techniques consistently validated successful structural modifications.

  • ¹H and ¹³C NMR confirmed substitution patterns and cyclization events.
  • Downfield phenolic OH signals supported intramolecular hydrogen bonding.
  • FT-IR spectroscopy verified quinone carbonyl retention and new heterocyclic functionalities.
  • HRMS provided accurate molecular weight confirmation and elemental composition.
  • Single-crystal X-ray diffraction definitively confirmed fused ring formation and hydrogen bonding networks.
  • DFT calculations correlated electronic parameters (HOMO–LUMO gap, charge density) with redox reactivity.
  • Molecular docking studies predicted strong binding interactions with targets such as NQO1, topoisomerase II, α-glucosidase, DHFR, and acetylcholinesterase.

The integration of experimental and computational tools strengthened structure–activity relationship (SAR) interpretation and provided rational direction for future molecular design.

7.3 Chemo-Biological Evaluation

Anticancer Activity

The majority of lawsone derivatives exhibited cytotoxic effects via redox cycling and ROS generation. Fused heterocyclic derivatives and Mannich bases exhibited potent apoptosis induction compared to lawsone. Electron-withdrawing groups increased the potency of anticancer activity.

The compounds structurally analogous to β-lapachone exhibited promising selectivity against cancer cells that overexpress NQO1.

Antimicrobial Activity

minoalkylated and sulfur-containing derivatives exhibited improved antibacterial and antifungal activities. Enhanced lipophilicity increased the permeability of the compounds, and quinone-mediated oxidative stress damaged the microbial cells.

Antimalarial Activity

The hybrid compounds exhibited potent Plasmodium enzyme inhibition and disruption of heme detoxification pathways. Redox-mediated oxidative stress in infected erythrocytes is a major mechanism of antimalarial activity.

Antidiabetic and Enzyme Inhibition

The compounds exhibited potent inhibition of α-glucosidase, PTP1B, and acetylcholinesterase. SAR analysis revealed that hydrogen bonding and π-stacking interactions significantly increased the efficiency of enzyme inhibition activity. Moderate lipophilicity increased the binding affinity to the enzymes.

Cardiovascular and Antiplatelet Activity

The quinone derivatives exhibited potent antiplatelet and cardiovascular effects by reducing platelet aggregation and oxidative stress markers. Redox modulation and nitric oxide-mediated pathways may be responsible for the cardiovascular effects.

7.4 Structure–Activity Relationship Insights

Comprehensive SAR analysis revealed the following trends:

  • The quinone core is essential for biological activity.
  • Free phenolic –OH enhances hydrogen bonding and enzyme inhibition.
  • C-3 substitution improves solubility and target interaction.
  • Heterocyclic fusion increases rigidity and π-stacking capacity.
  • Moderate lipophilicity optimizes cell permeability.
  • Excessive redox potential may increase toxicity.

Electronic parameters such as HOMO–LUMO gap showed correlation with cytotoxic potency, supporting computational-guided optimization.

7.5 Toxicity and Pharmacokinetic Considerations

While biological activity is promising, redox cycling remains a double-edged sword. Excessive ROS generation can induce hepatotoxicity and systemic oxidative damage. Covalent protein adduct formation and glutathione depletion were identified as potential risk mechanisms.

Pharmacokinetic limitations include:

  • Rapid metabolic reduction
  • Poor aqueous solubility (in some derivatives)
  • Limited in vivo stability

Many simple derivatives satisfy Lipinski’s Rule of Five; however, heavily fused systems may exceed optimal molecular weight and lipophilicity limits. Therefore, rational structural tuning and in vivo validation remain critical before clinical translation.

CONCLUSION

The present review highlights the significant advancements achieved in the chemistry and pharmacology of lawsone-derived heterocyclic compounds. Lawsone serves as a highly versatile scaffold due to its reactive quinone system, enabling extensive structural diversification through multicomponent reactions, Mannich condensation, heterocyclic fusion, and hybrid molecule design.

Synthetic developments have provided efficient and sustainable methodologies for constructing structurally complex derivatives. Green chemistry approaches—including microwave-assisted synthesis, aqueous media, solvent-free protocols, and nanocatalysis—have significantly improved environmental compatibility while maintaining high yields and operational simplicity.

Comprehensive structural elucidation using NMR, FT-IR, HRMS, X-ray crystallography, and computational modeling has enabled precise characterization and rational structure–activity correlation. Integration of experimental and in silico methods has strengthened predictive drug design strategies.

Biological investigations reveal that lawsone derivatives possess broad-spectrum activities, including anticancer, antimicrobial, antimalarial, antidiabetic, and cardiovascular effects. Structural modifications at the C-3 position and heterocyclic fusion consistently enhance pharmacological performance. However, the redox-active quinone nucleus, while essential for therapeutic activity, also contributes to potential toxicity through oxidative stress and covalent protein interactions.

Future research should focus on:

  • Fine-tuning redox potential to maximize selectivity
  • Improving pharmacokinetic stability and bioavailability
  • Expanding hybrid drug design strategies
  • Conducting systematic in vivo and preclinical evaluations
  • Exploring nanoformulation and targeted delivery systems

In conclusion, lawsone-derived heterocycles represent a promising class of multifunctional bioactive molecules. With continued optimization of synthetic strategies, molecular design, and safety profiling, these compounds hold considerable potential for development into clinically relevant therapeutic agents.

REFERENCES

  1. Ali BH, Bashir AK, Tanira MO. Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis. Phytother Res. 1995;9(6):427–431.
    Hegnauer R. Chemotaxonomie der Pflanzen. Vol 8. Basel: Birkhäuser Verlag; 1989.
  2. Mikhaeil BR, Badria FA, Maatooq GT, Amer MM. Antioxidant and immunomodulatory constituents of Lawsonia inermis. Z Naturforsch C. 2004;59(7–8):468–476.
  3. Semwal RB, Semwal DK, Combrinck S, Viljoen A. Lawsonia inermis L. (henna): Ethnobotanical, phytochemical and pharmacological aspects. J Ethnopharmacol. 2014;155(1):80–103.
  4. Al-Snafi AE. The pharmacological and therapeutic importance of Lawsonia inermis. Int J Pharm Rev Res. 2019;9(3):1–8.
  5. O’Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1–41.
  6. Siva R. Status of natural dyes and dye-yielding plants in India. Curr Sci. 2007;92(7):916–925.
  7. Hossain MA, Al-Raqmi KA, Al-Mijizy ZH, Weli AM, Al-Riyami Q. Study of total phenol, flavonoids contents and phytochemical screening of various leaves crude extracts of Lawsonia inermis. J Chem Pharm Res. 2013;5(12):83–88.
  8. Babula P, Adam V, Havel L, Kizek R. Noteworthy secondary metabolites naphthoquinones – their occurrence, pharmacological properties and analysis. Curr Pharm Anal. 2009;5(1):47–68.
  9. Pinto AV, de Castro SL. The trypanocidal activity of naphthoquinones: a review. Molecules. 2009;14(11):4570–4590.
  10. Thomson RH. Naturally occurring quinones. 2nd ed. London: Academic Press; 1971
  11. Fieser LF, Fieser M. Quinones in organic chemistry. Reinhold Publishing; 1961.
  12. Moore HW, Czerniak R. Naturally occurring quinones as potential bioreductive alkylating agents. Med Res Rev. 1981;1(3):249–280.
  13. Patai S, Rappoport Z. The Chemistry of Quinonoid Compounds. Wiley; 1988.
  14. Dam H. The discovery of vitamin K. Biochem J. 1935;29(6):1273–1285.
  15. Bolton JL, Dunlap T. Formation and biological targets of quinones: cytotoxic versus cytoprotective effects. Chem Res Toxicol. 2017;30(1):13–37.
  16. Li CJ, Li RW, Wang Y, et al. β-Lapachone: biological activities and therapeutic potential. Eur J Med Chem. 2019;182:111621.
  17. Dömling A, Wang W, Wang K. Chemistry and biology of multicomponent reactions. Chem Rev. 2012;112(6):3083–3135.
  18. Singh DK, Sharma S, Kumar S. Synthetic transformations of lawsone and its biological applications. Eur J Med Chem. 2012;54:1–18.
  19. Heravi MM, Zadsirjan V. Multicomponent reactions involving naphthoquinones: recent advances. RSC Adv. 2020;10:44247–44272.
  20. Chandrakar K, Shukla PK, Tiwari VK. Recent developments in multicomponent synthesis of lawsone derivatives. Curr Org Synth. 2023;20(2):123–145.
  21. Khurana JM, Magoo D. Efficient synthesis of aminoalkylated naphthoquinones via Mannich multicomponent reactions. Tetrahedron Lett. 2009;50(52):7300–7303.
  22. Tramontini M, Angiolini L. Mannich Bases: Chemistry and Uses. CRC Press; 1994.
  23. Singh DK, Sharma S, Kumar S. Synthetic transformations of lawsone and its biological applications. Eur J Med Chem. 2012;54:1–18.
  24. Khurana JM, Magoo D. Efficient synthesis of Mannich bases of naphthoquinones. Tetrahedron Lett. 2009;50(52):7300–7303.
  25. Heravi MM, Zadsirjan V. Recent advances in heterocycle synthesis via Mannich reactions. RSC Adv. 2020;10:44247–44272.
  26. Safari J, Zarnegar Z. Green Mannich reactions catalyzed by nanomaterials. RSC Adv. 2014;4:17808–17838.
  27. Kappe CO. Controlled microwave heating in modern organic synthesis. Angew Chem Int Ed. 2004;43(46):6250–6284
  28. da Silva AJM, Netto CD, Pacienza-Lima W, et al. Quinones as privileged structures in drug discovery. Mini Rev Med Chem. 2013;13(6):907–919.
  29. Pinto AV, de Castro SL. The trypanocidal activity of naphthoquinones: a review. Molecules. 2009;14(11):4570–4590.
  30. Supuran CT. Carbonic anhydrase inhibitors: quinone-based derivatives. J Enzyme Inhib Med Chem. 2016;31(3):345–360.
  31. Silva MN, Ferreira VF, Souza MCBV. Synthesis and biological evaluation of isoindolinone-naphthoquinone derivatives. Eur J Med Chem. 2010;45(10):4414-4421.
  32. Tandon VK, Maurya HK. Synthesis and cytotoxic evaluation of fused naphthoquinone derivatives. Bioorg Med Chem. 2009;17(6):2234-2241.
  33. Karthikeyan MS, Holla BS, Kumari NS. Synthesis of benzothiazine derivatives and their antimicrobial studies. Eur J Med Chem. 2007;42(1):30-36.
  34. Pingaew R, Prachayasittikul S, Prachayasittikul V. Synthesis and biological evaluation of sulfur-containing naphthoquinones. Med Chem Res. 2012;21(8):1986-1994.
  35. Pereira CP, Oliveira KM, Ferreira VF. Quinoxaline-naphthoquinone hybrids: synthesis and cytotoxic activity. Bioorg Med Chem Lett. 2011;21(2):676-679.
  36. Carta A, Loriga M, Paglietti G. Quinoxaline derivatives as antimicrobial and anticancer agents. Eur J Med Chem. 2004;39(2):195-203.
  37. da Silva AJM, Netto CD, Pacienza-Lima W. Thiazole-containing naphthoquinones as anticancer agents. Eur J Med Chem. 2012;55:72-80
  38. Kumar D, Kumar NM, Akamatsu K. Synthesis and biological evaluation of thiazole derivatives. Bioorg Med Chem Lett. 2010;20(13):3916-3919.
  39. Nepali K, Sharma S, Ojha R. Oxazole derivatives: synthesis and biological significance. Eur J Med Chem. 2014;77:422-487.
  40. Kumari M, Singh J, Dubey AK. Synthesis and evaluation of oxazole-containing naphthoquinones. Bioorg Chem. 2013;50:9-15.
  41. Kappe CO. Controlled microwave heating in modern organic synthesis. Angew Chem Int Ed. 2004;43(46):6250-6284.
  42. Lidström P, Tierney J, Wathey B, Westman J. Microwave assisted organic synthesis—a review. Tetrahedron. 2001;57(45):9225-9283.
  43. Li CJ, Chan TH. Organic reactions in aqueous media. Chem Rev. 1997;97(7):2341-2372.
  44. Sheldon RA. Green solvents for sustainable organic synthesis. Green Chem. 2005;7(5):267-278.
  45. Hollmann F, Arends IWCE, Buehler K. Biocatalytic redox reactions for organic synthesis. ChemCatChem. 2010;2(7):762-782.
  46. Polshettiwar V, Varma RS. Green chemistry by nano-catalysis. Green Chem. 2010;12(5):743-754.
  47. Mason TJ, Peters D. Practical sonochemistry in organic synthesis. Ultrason Sonochem. 2002;9(4):187-191.
  48. James SL, Adams CJ, Bolm C, et al. Mechanochemistry: opportunities for green synthesis. Chem Soc Rev. 2012;41(1):413-447.
  49. Habbal O, Hasson SS, El-Hag AH, Al-Mahrooqi Z, Al-Hashmi N, Al-Bimani Z. Antimicrobial activity of Lawsonia inermis and its extraction methods. J Ethnopharmacol. 2011;137(1):124-128.
  50. Claridge TDW. High-resolution NMR techniques in organic chemistry. Tetrahedron Org Chem Ser. 2009;27:1-372
  51. Breitmaier E. Structure elucidation by NMR in organic chemistry. Wiley. 2002;1-258
  52. Silverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. Wiley. 2005;1-512
  53. Gross JH. Mass spectrometry: a textbook. Springer. 2011;1-752.
  54. Glusker JP, Lewis M, Rossi M. Crystal structure analysis for chemists and biologists. Wiley. 1994;1-854
  55. Desiraju GR. Crystal engineering: the design of organic solids. Elsevier. 1989;1-312.
  56. Parr RG, Yang W. Density-functional theory of atoms and molecules. Oxford University Press. 1989;1-333.
  57. Morris GM, Huey R, Olson AJ. Using AutoDock for molecular docking. J Comput Chem. 2008;29(16):2785-2791.
  58. Li CJ, Li YZ, Pinto AV, Pardee AB. Potent inhibition of tumor cells by β-lapachone. Proc Natl Acad Sci USA. 1999;96(23):13369-13374.
  59. Tandon VK, Yadav DB. Synthesis and anticancer activity of Mannich bases of naphthoquinones. Bioorg Med Chem Lett. 2004;14(11):2901-2904.
  60. da Silva AJM, Netto CD, Pacienza-Lima W. Thiazole-containing naphthoquinones as anticancer agents. Eur J Med Chem. 2012;55:72-80.
  61. Kumagai Y, Shinkai Y, Miura T, Cho AK. The chemical biology of naphthoquinones. Annu Rev Pharmacol Toxicol. 2012;52:221-247.
  62. Morris GM, Huey R, Olson AJ. Using AutoDock for molecular docking studies. J Comput Chem. 2008;29(16):2785-2791.
  63. Habbal O, Hasson SS, El-Hag AH, et al. Antimicrobial activity of Lawsonia inermis extracts. J Ethnopharmacol. 2011;137(1):124-128.
  64. Karthikeyan MS, Holla BS. Synthesis of Mannich bases and antimicrobial evaluation. Eur J Med Chem. 2007;42(1):30-36.
  65. Pingaew R, Prachayasittikul S. Synthesis of benzothiazine derivatives with antifungal activity. Med Chem Res. 2012;21(8):1986-1994.
  66. O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1-41.
  67. Croft SL, O’Neill PM. Antimalarial activity of naphthoquinones. Bioorg Med Chem. 2002;10(5):1119-1128.
  68. Kapadia GJ, Azuine MA. Antiplasmodial activity of quinone derivatives. Phytother Res. 2001;15(4):273-276.
  69. Yuthavong Y, Tarnchompoo B. Targeting malarial DHFR. Proc Natl Acad Sci USA. 2012;109(42):16823-16828.
  70. Kim YM, Jeong YK, Wang MH. Inhibitory effect of natural quinones on α-glucosidase. Nutrition. 2005;21(6):756-761.
  71. Zhang S, Zhang ZY. PTP1B inhibitors as antidiabetic agents. Drug Discov Today. 2007;12(9-10):373-381.
  72. Orhan IE, Kartal M. Acetylcholinesterase inhibitory activity of natural quinones. Food Chem Toxicol. 2008;46(9):3022-3030.
  73. Morris GM, Huey R. AutoDock docking methodology. J Comput Chem. 2008;29(16):2785-2791.
  74. Jin YR, Han XH. Antiplatelet activity of quinone derivatives. Thromb Res. 2004;113(3-4):221-230.
  75. da Silva AJM, Costa PRR. Cardiovascular effects of naphthoquinones. Eur J Med Chem. 2013;60:373-379.
  76. Bolton JL, Dunlap T. Formation and biological targets of quinones. Chem Res Toxicol. 2017;30(1):13-37.
  77. Ignarro LJ. Nitric oxide and cardiovascular pharmacology. Circulation. 2002;105(18):2133-2135.
  78. Bolton JL, Dunlap T. Formation and biological targets of quinones. Chem Res Toxicol. 2017;30(1):13-37.
  79. Kumagai Y, Shinkai Y, Miura T, Cho AK. The chemical biology of naphthoquinones. Annu Rev Pharmacol Toxicol. 2012;52:221-247.
  80. O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1-41.
  81. Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG. Quinone chemistry and toxicity. Toxicol Appl Pharmacol. 1992;112(1):2-16.
  82. Tandon VK, Maurya HK. Mannich bases of naphthoquinones as anticancer agents. Bioorg Med Chem. 2009;17(6):2234-2241
  83. da Silva AJM, Netto CD. Structure-activity studies of naphthoquinone derivatives. Eur J Med Chem. 2012;55:72-80.
  84. Kumar D, Kumar NM. Thiazole-containing naphthoquinones and biological evaluation. Bioorg Med Chem Lett. 2010;20(13):3916-3919.
  85. Carta A, Loriga M, Paglietti G. Quinoxaline derivatives as antimicrobial agents. Eur J Med Chem. 2004;39(2):195-203.
  86. Nepali K, Sharma S, Ojha R. Halogenated quinones in medicinal chemistry. Eur J Med Chem. 2014;77:422-487.
  87. Parr RG, Yang W. Density functional theory of atoms and molecules. Oxford University Press. 1989;1-333.
  88. Morphy R, Rankovic Z. Designed multiple ligands in drug discovery. J Med Chem. 2005;48(21):6523-6543.
  89. Morris GM, Huey R, Olson AJ. AutoDock docking studies. J Comput Chem. 2008;29(16):2785-2791.
  90. Li CJ, Li YZ, Pinto AV, Pardee AB. Selective tumor cell killing by quinones. Proc Natl Acad Sci USA. 1999;96(23):13369-13374.
  91. O’Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1-41.
  92. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol. 2000;13(3):135-160.
  93. Monks TJ, Lau SS. Reactive intermediates and protein adduct formation. Toxicol Lett. 1998;102-103:41-44.
  94. Jaeschke H, McGill MR. Oxidative stress and hepatotoxicity. Hepatology. 2015;61(2):686-695.
  95. Kumagai Y, Cho AK. Mechanisms of quinone-induced hepatotoxicity. Toxicol Appl Pharmacol. 1997;143(2):247-256.
  96. Ross D, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1) and toxicity modulation. Free Radic Biol Med. 2017;112:236-246.
  97. Olson H, Betton G, Robinson D, et al. Concordance of toxicity in animals and humans. Regul Toxicol Pharmacol. 2000;32(1):56-67.
  98. Lin JH, Lu AYH. Role of pharmacokinetics in drug development. Clin Pharmacokinet. 1997;32(3):210-258.
  99. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability. Adv Drug Deliv Rev. 2001;46(1-3):3-26.
  100. Di L, Kerns EH. Drug-like properties: concepts, structure design and methods. Academic Press. 2015;1-450.
  101. van de Waterbeemd H, Gifford E. ADMET prediction in drug discovery. Nat Rev Drug Discov. 2003;2(3):192-204.
    .

Reference

  1. Ali BH, Bashir AK, Tanira MO. Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis. Phytother Res. 1995;9(6):427–431.
    Hegnauer R. Chemotaxonomie der Pflanzen. Vol 8. Basel: Birkhäuser Verlag; 1989.
  2. Mikhaeil BR, Badria FA, Maatooq GT, Amer MM. Antioxidant and immunomodulatory constituents of Lawsonia inermis. Z Naturforsch C. 2004;59(7–8):468–476.
  3. Semwal RB, Semwal DK, Combrinck S, Viljoen A. Lawsonia inermis L. (henna): Ethnobotanical, phytochemical and pharmacological aspects. J Ethnopharmacol. 2014;155(1):80–103.
  4. Al-Snafi AE. The pharmacological and therapeutic importance of Lawsonia inermis. Int J Pharm Rev Res. 2019;9(3):1–8.
  5. O’Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1–41.
  6. Siva R. Status of natural dyes and dye-yielding plants in India. Curr Sci. 2007;92(7):916–925.
  7. Hossain MA, Al-Raqmi KA, Al-Mijizy ZH, Weli AM, Al-Riyami Q. Study of total phenol, flavonoids contents and phytochemical screening of various leaves crude extracts of Lawsonia inermis. J Chem Pharm Res. 2013;5(12):83–88.
  8. Babula P, Adam V, Havel L, Kizek R. Noteworthy secondary metabolites naphthoquinones – their occurrence, pharmacological properties and analysis. Curr Pharm Anal. 2009;5(1):47–68.
  9. Pinto AV, de Castro SL. The trypanocidal activity of naphthoquinones: a review. Molecules. 2009;14(11):4570–4590.
  10. Thomson RH. Naturally occurring quinones. 2nd ed. London: Academic Press; 1971
  11. Fieser LF, Fieser M. Quinones in organic chemistry. Reinhold Publishing; 1961.
  12. Moore HW, Czerniak R. Naturally occurring quinones as potential bioreductive alkylating agents. Med Res Rev. 1981;1(3):249–280.
  13. Patai S, Rappoport Z. The Chemistry of Quinonoid Compounds. Wiley; 1988.
  14. Dam H. The discovery of vitamin K. Biochem J. 1935;29(6):1273–1285.
  15. Bolton JL, Dunlap T. Formation and biological targets of quinones: cytotoxic versus cytoprotective effects. Chem Res Toxicol. 2017;30(1):13–37.
  16. Li CJ, Li RW, Wang Y, et al. β-Lapachone: biological activities and therapeutic potential. Eur J Med Chem. 2019;182:111621.
  17. Dömling A, Wang W, Wang K. Chemistry and biology of multicomponent reactions. Chem Rev. 2012;112(6):3083–3135.
  18. Singh DK, Sharma S, Kumar S. Synthetic transformations of lawsone and its biological applications. Eur J Med Chem. 2012;54:1–18.
  19. Heravi MM, Zadsirjan V. Multicomponent reactions involving naphthoquinones: recent advances. RSC Adv. 2020;10:44247–44272.
  20. Chandrakar K, Shukla PK, Tiwari VK. Recent developments in multicomponent synthesis of lawsone derivatives. Curr Org Synth. 2023;20(2):123–145.
  21. Khurana JM, Magoo D. Efficient synthesis of aminoalkylated naphthoquinones via Mannich multicomponent reactions. Tetrahedron Lett. 2009;50(52):7300–7303.
  22. Tramontini M, Angiolini L. Mannich Bases: Chemistry and Uses. CRC Press; 1994.
  23. Singh DK, Sharma S, Kumar S. Synthetic transformations of lawsone and its biological applications. Eur J Med Chem. 2012;54:1–18.
  24. Khurana JM, Magoo D. Efficient synthesis of Mannich bases of naphthoquinones. Tetrahedron Lett. 2009;50(52):7300–7303.
  25. Heravi MM, Zadsirjan V. Recent advances in heterocycle synthesis via Mannich reactions. RSC Adv. 2020;10:44247–44272.
  26. Safari J, Zarnegar Z. Green Mannich reactions catalyzed by nanomaterials. RSC Adv. 2014;4:17808–17838.
  27. Kappe CO. Controlled microwave heating in modern organic synthesis. Angew Chem Int Ed. 2004;43(46):6250–6284
  28. da Silva AJM, Netto CD, Pacienza-Lima W, et al. Quinones as privileged structures in drug discovery. Mini Rev Med Chem. 2013;13(6):907–919.
  29. Pinto AV, de Castro SL. The trypanocidal activity of naphthoquinones: a review. Molecules. 2009;14(11):4570–4590.
  30. Supuran CT. Carbonic anhydrase inhibitors: quinone-based derivatives. J Enzyme Inhib Med Chem. 2016;31(3):345–360.
  31. Silva MN, Ferreira VF, Souza MCBV. Synthesis and biological evaluation of isoindolinone-naphthoquinone derivatives. Eur J Med Chem. 2010;45(10):4414-4421.
  32. Tandon VK, Maurya HK. Synthesis and cytotoxic evaluation of fused naphthoquinone derivatives. Bioorg Med Chem. 2009;17(6):2234-2241.
  33. Karthikeyan MS, Holla BS, Kumari NS. Synthesis of benzothiazine derivatives and their antimicrobial studies. Eur J Med Chem. 2007;42(1):30-36.
  34. Pingaew R, Prachayasittikul S, Prachayasittikul V. Synthesis and biological evaluation of sulfur-containing naphthoquinones. Med Chem Res. 2012;21(8):1986-1994.
  35. Pereira CP, Oliveira KM, Ferreira VF. Quinoxaline-naphthoquinone hybrids: synthesis and cytotoxic activity. Bioorg Med Chem Lett. 2011;21(2):676-679.
  36. Carta A, Loriga M, Paglietti G. Quinoxaline derivatives as antimicrobial and anticancer agents. Eur J Med Chem. 2004;39(2):195-203.
  37. da Silva AJM, Netto CD, Pacienza-Lima W. Thiazole-containing naphthoquinones as anticancer agents. Eur J Med Chem. 2012;55:72-80
  38. Kumar D, Kumar NM, Akamatsu K. Synthesis and biological evaluation of thiazole derivatives. Bioorg Med Chem Lett. 2010;20(13):3916-3919.
  39. Nepali K, Sharma S, Ojha R. Oxazole derivatives: synthesis and biological significance. Eur J Med Chem. 2014;77:422-487.
  40. Kumari M, Singh J, Dubey AK. Synthesis and evaluation of oxazole-containing naphthoquinones. Bioorg Chem. 2013;50:9-15.
  41. Kappe CO. Controlled microwave heating in modern organic synthesis. Angew Chem Int Ed. 2004;43(46):6250-6284.
  42. Lidström P, Tierney J, Wathey B, Westman J. Microwave assisted organic synthesis—a review. Tetrahedron. 2001;57(45):9225-9283.
  43. Li CJ, Chan TH. Organic reactions in aqueous media. Chem Rev. 1997;97(7):2341-2372.
  44. Sheldon RA. Green solvents for sustainable organic synthesis. Green Chem. 2005;7(5):267-278.
  45. Hollmann F, Arends IWCE, Buehler K. Biocatalytic redox reactions for organic synthesis. ChemCatChem. 2010;2(7):762-782.
  46. Polshettiwar V, Varma RS. Green chemistry by nano-catalysis. Green Chem. 2010;12(5):743-754.
  47. Mason TJ, Peters D. Practical sonochemistry in organic synthesis. Ultrason Sonochem. 2002;9(4):187-191.
  48. James SL, Adams CJ, Bolm C, et al. Mechanochemistry: opportunities for green synthesis. Chem Soc Rev. 2012;41(1):413-447.
  49. Habbal O, Hasson SS, El-Hag AH, Al-Mahrooqi Z, Al-Hashmi N, Al-Bimani Z. Antimicrobial activity of Lawsonia inermis and its extraction methods. J Ethnopharmacol. 2011;137(1):124-128.
  50. Claridge TDW. High-resolution NMR techniques in organic chemistry. Tetrahedron Org Chem Ser. 2009;27:1-372
  51. Breitmaier E. Structure elucidation by NMR in organic chemistry. Wiley. 2002;1-258
  52. Silverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. Wiley. 2005;1-512
  53. Gross JH. Mass spectrometry: a textbook. Springer. 2011;1-752.
  54. Glusker JP, Lewis M, Rossi M. Crystal structure analysis for chemists and biologists. Wiley. 1994;1-854
  55. Desiraju GR. Crystal engineering: the design of organic solids. Elsevier. 1989;1-312.
  56. Parr RG, Yang W. Density-functional theory of atoms and molecules. Oxford University Press. 1989;1-333.
  57. Morris GM, Huey R, Olson AJ. Using AutoDock for molecular docking. J Comput Chem. 2008;29(16):2785-2791.
  58. Li CJ, Li YZ, Pinto AV, Pardee AB. Potent inhibition of tumor cells by β-lapachone. Proc Natl Acad Sci USA. 1999;96(23):13369-13374.
  59. Tandon VK, Yadav DB. Synthesis and anticancer activity of Mannich bases of naphthoquinones. Bioorg Med Chem Lett. 2004;14(11):2901-2904.
  60. da Silva AJM, Netto CD, Pacienza-Lima W. Thiazole-containing naphthoquinones as anticancer agents. Eur J Med Chem. 2012;55:72-80.
  61. Kumagai Y, Shinkai Y, Miura T, Cho AK. The chemical biology of naphthoquinones. Annu Rev Pharmacol Toxicol. 2012;52:221-247.
  62. Morris GM, Huey R, Olson AJ. Using AutoDock for molecular docking studies. J Comput Chem. 2008;29(16):2785-2791.
  63. Habbal O, Hasson SS, El-Hag AH, et al. Antimicrobial activity of Lawsonia inermis extracts. J Ethnopharmacol. 2011;137(1):124-128.
  64. Karthikeyan MS, Holla BS. Synthesis of Mannich bases and antimicrobial evaluation. Eur J Med Chem. 2007;42(1):30-36.
  65. Pingaew R, Prachayasittikul S. Synthesis of benzothiazine derivatives with antifungal activity. Med Chem Res. 2012;21(8):1986-1994.
  66. O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1-41.
  67. Croft SL, O’Neill PM. Antimalarial activity of naphthoquinones. Bioorg Med Chem. 2002;10(5):1119-1128.
  68. Kapadia GJ, Azuine MA. Antiplasmodial activity of quinone derivatives. Phytother Res. 2001;15(4):273-276.
  69. Yuthavong Y, Tarnchompoo B. Targeting malarial DHFR. Proc Natl Acad Sci USA. 2012;109(42):16823-16828.
  70. Kim YM, Jeong YK, Wang MH. Inhibitory effect of natural quinones on α-glucosidase. Nutrition. 2005;21(6):756-761.
  71. Zhang S, Zhang ZY. PTP1B inhibitors as antidiabetic agents. Drug Discov Today. 2007;12(9-10):373-381.
  72. Orhan IE, Kartal M. Acetylcholinesterase inhibitory activity of natural quinones. Food Chem Toxicol. 2008;46(9):3022-3030.
  73. Morris GM, Huey R. AutoDock docking methodology. J Comput Chem. 2008;29(16):2785-2791.
  74. Jin YR, Han XH. Antiplatelet activity of quinone derivatives. Thromb Res. 2004;113(3-4):221-230.
  75. da Silva AJM, Costa PRR. Cardiovascular effects of naphthoquinones. Eur J Med Chem. 2013;60:373-379.
  76. Bolton JL, Dunlap T. Formation and biological targets of quinones. Chem Res Toxicol. 2017;30(1):13-37.
  77. Ignarro LJ. Nitric oxide and cardiovascular pharmacology. Circulation. 2002;105(18):2133-2135.
  78. Bolton JL, Dunlap T. Formation and biological targets of quinones. Chem Res Toxicol. 2017;30(1):13-37.
  79. Kumagai Y, Shinkai Y, Miura T, Cho AK. The chemical biology of naphthoquinones. Annu Rev Pharmacol Toxicol. 2012;52:221-247.
  80. O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1-41.
  81. Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG. Quinone chemistry and toxicity. Toxicol Appl Pharmacol. 1992;112(1):2-16.
  82. Tandon VK, Maurya HK. Mannich bases of naphthoquinones as anticancer agents. Bioorg Med Chem. 2009;17(6):2234-2241
  83. da Silva AJM, Netto CD. Structure-activity studies of naphthoquinone derivatives. Eur J Med Chem. 2012;55:72-80.
  84. Kumar D, Kumar NM. Thiazole-containing naphthoquinones and biological evaluation. Bioorg Med Chem Lett. 2010;20(13):3916-3919.
  85. Carta A, Loriga M, Paglietti G. Quinoxaline derivatives as antimicrobial agents. Eur J Med Chem. 2004;39(2):195-203.
  86. Nepali K, Sharma S, Ojha R. Halogenated quinones in medicinal chemistry. Eur J Med Chem. 2014;77:422-487.
  87. Parr RG, Yang W. Density functional theory of atoms and molecules. Oxford University Press. 1989;1-333.
  88. Morphy R, Rankovic Z. Designed multiple ligands in drug discovery. J Med Chem. 2005;48(21):6523-6543.
  89. Morris GM, Huey R, Olson AJ. AutoDock docking studies. J Comput Chem. 2008;29(16):2785-2791.
  90. Li CJ, Li YZ, Pinto AV, Pardee AB. Selective tumor cell killing by quinones. Proc Natl Acad Sci USA. 1999;96(23):13369-13374.
  91. O’Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991;80(1):1-41.
  92. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol. 2000;13(3):135-160.
  93. Monks TJ, Lau SS. Reactive intermediates and protein adduct formation. Toxicol Lett. 1998;102-103:41-44.
  94. Jaeschke H, McGill MR. Oxidative stress and hepatotoxicity. Hepatology. 2015;61(2):686-695.
  95. Kumagai Y, Cho AK. Mechanisms of quinone-induced hepatotoxicity. Toxicol Appl Pharmacol. 1997;143(2):247-256.
  96. Ross D, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1) and toxicity modulation. Free Radic Biol Med. 2017;112:236-246.
  97. Olson H, Betton G, Robinson D, et al. Concordance of toxicity in animals and humans. Regul Toxicol Pharmacol. 2000;32(1):56-67.
  98. Lin JH, Lu AYH. Role of pharmacokinetics in drug development. Clin Pharmacokinet. 1997;32(3):210-258.
  99. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability. Adv Drug Deliv Rev. 2001;46(1-3):3-26.
  100. Di L, Kerns EH. Drug-like properties: concepts, structure design and methods. Academic Press. 2015;1-450.

van de Waterbeemd H, Gifford E. ADMET prediction in drug discovery. Nat Rev Drug Discov. 2003;2(3):192-204.

Photo
Manojkumar R.
Corresponding author

J.K.K. Nattraja College of Pharmacy, Kumarapalayam – 638 183, Namakkal District, Tamil Nadu, India. Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai.

Photo
Gowtham A.
Co-author

J.K.K. Nattraja College of Pharmacy, Kumarapalayam – 638 183, Namakkal District, Tamil Nadu, India. Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai.

Photo
Nandhakumar S.
Co-author

J.K.K. Nattraja College of Pharmacy, Kumarapalayam – 638 183, Namakkal District, Tamil Nadu, India. Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai.

Photo
Balaji A.
Co-author

J.K.K. Nattraja College of Pharmacy, Kumarapalayam – 638 183, Namakkal District, Tamil Nadu, India. Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai.

Photo
Devi P.
Co-author

Department of Pharmaceutical Chemistry, J.K.K. Nattraja College of Pharmacy, Kumarapalayam – 638 183, Namakkal District, Tamil Nadu, India.

Photo
Vijayabaskaran M.
Co-author

Department of Pharmaceutical Chemistry, J.K.K. Nattraja College of Pharmacy, Kumarapalayam – 638 183, Namakkal District, Tamil Nadu, India.

Manojkumar R., Gowtham A., Nandhakumar S., Balaji A., Devi P., Vijayabaskaran M., Recent Advancements in Lawsone-Derived Heterocyclic Compounds: Synthesis, Structural Elucidation, and Chemo-Biological Applications, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 950-969 https://doi.org/10.5281/zenodo.19448606

More related articles
Formulation and Evaluation of Antimicrobial Herbal...
Tejaswini Mare, Swapnali Karle, Jatin Kudnar, ...
Network Pharmacology and Molecular Docking of Mucu...
Akshaya P., Anusree S., Rupitha N. S., Liya S. Saji, Shabin P., J...
Ameliorative effect of omega 3 Fatty acid on Cyper...
Rinku, Shivkant Sharma, Dhirender Kaushik, ...
Development of Herbal Body Wash with Antioxidants and Antimicrobial Properties...
Dr. Gururaj Kulkarni, Adithi P., Shwetha S. Reddy, Yashaswini S. M., Amulya S., Anand, Krishna R., ...
Silica Encapsulated Curcumin: A Transdermal Patch for Enhanced Sustained Drug Re...
Ansua Roy, Satadal Das, Saswati Saha, Sourav Adhikary, Mahua Ghosh Chaudhuri, ...
Related Articles
Formulation And Evaluation Of Anti-Acne Herbal Gel...
Mufeeda Mohammad Ali, Haneena Swafiya A, Hasanath P, Marjhan rafeeq, Sharafa BK, Dr Arun Kumar KV, ...
Creation And Evaluation Of Multi Herbal Fairness Cream By Using Carica Papaya An...
Manisha U. Mishra , Aishwarya A. Jain, Prachi S. Patle, Pratibha U. Thakur, Priyanshi A. Ramteke, Ri...
Formulation and Evaluation of Herbal Perfumes...
Anjali Rathod, Komal Amate, Ashwini Ujgare, Anil Muthanwad, Nandkumar Giri, Komal Bahalaskar, ...
More related articles
Network Pharmacology and Molecular Docking of Mucuna Pruriens in Treatment of De...
Akshaya P., Anusree S., Rupitha N. S., Liya S. Saji, Shabin P., Jyothi B. N., Kiran K. J., Prasobh G...
Network Pharmacology and Molecular Docking of Mucuna Pruriens in Treatment of De...
Akshaya P., Anusree S., Rupitha N. S., Liya S. Saji, Shabin P., Jyothi B. N., Kiran K. J., Prasobh G...